Reports FY22 revenue $8.8M vs $10.3M last year. "Within our Dental Segment, we made a number of key changes to our overall sales and marketing strategy that we believe will support and enhance our long-term growth. In the U.S., we launched a new online store for US dentists to order the STA Single Tooth Anesthesia System Instruments and Handpieces, and ended the agreement with our prior distributor as we exited 2022. This new site went live on January 3, 2023. While this change in US distribution strategy resulted in lower fourth quarter of 2022 sales, as the prior distributor wound down its operations, we expect our new direct online channel will provide us with a closer relationship to our customers and better margins. Additionally, we experienced continued growth in international sales, excluding China. Overall, we remain encouraged by the growing interest in both our dental and medical products."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MLSS:
- Milestone Scientific Provides 2022 Year-End Business Update
- Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the University Pain and Spine Center which Operates 7 Locations Across New Jersey and New York
- Milestone Scientific sells CompuFlo at University Pain and Spine Center
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics